Simdax Innrennslisþykkni, lausn 2,5 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

simdax innrennslisþykkni, lausn 2,5 mg/ml

orion corporation - levosimendanum inn - innrennslisþykkni, lausn - 2,5 mg/ml

Yesafili Evrópusambandið - íslenska - EMA (European Medicines Agency)

yesafili

viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - augnlækningar - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.

Bloxazoc Forðatafla 100 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

bloxazoc forðatafla 100 mg

krka d.d. novo mesto - metoprololum súkkínat - forðatafla - 100 mg

Seloken ZOC Forðatafla 95 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

seloken zoc forðatafla 95 mg

recordati ireland limited* - metoprololum súkkínat - forðatafla - 95 mg